Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy
Prostate
Prostate
Prostate
N/A
Kirschner, Austin
VICCURO16112
Ocular Tumor Tissue Acquisition to Study Biologic Correlates of Disease
Multiple Cancer Types
Pediatrics,
Retinoblastoma (Pediatrics)
N/A
Daniels, Anthony
VICCPED16115
Using Biomarkers and Imaging in Fungal Regions to Improve Lung Cancer Diagnosis
Lung
Lung
Lung
N/A
Grogan, Eric
VICCTHO1764
Chemotherapy Levels in the Blood of Patients with Retinoblastoma
Retinoblastoma (Pediatrics)
Retinoblastoma (Pediatrics)
Retinoblastoma (Pediatrics)
N/A
Daniels, Anthony
VICCREACH1792
Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma
Multiple Cancer Types
Neuro-Oncology,
Pediatrics
N/A
Esbenshade, Adam
VICCPED17108
Optimization of Therapy Using Immune Effector Cells
Hematologic
Hematologic
Hematologic
N/A
Oluwole, Olalekan
VICCCTT1834
Integrating Comprehensive Precision Tobacco Treatment for Patients with Cancer
Miscellaneous
Miscellaneous
Miscellaneous
N/A
Tindle, Hilary
VICCTHO1886
Nashville Biosciences Blood Sample Collection Study
Multiple Cancer Types
Colon,
Liver,
Lung,
Non Small Cell,
Ovarian,
Pancreatic,
Rectal
N/A
Bernard, Gordon
VICCMD18123
A Study of the Drugs Selumetinib versus Carboplatin/Vincristine in Patients with Neurofibromatosis and Low-Grade Glioma
Multiple Cancer Types
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Neuro-Oncology,
Pediatrics
III
Pastakia, Devang
NCT03871257
COGACNS1831